RecruitingNCT04310787
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
The Investigation on Long-term Outcomes and Prognostic Factors of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Enrollment
300 participants
Start Date
May 15, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria4
- Age from 18 to 65 years old;
- The diagnosis consistent with hepatitis b associated chronic acute liver failure;
- After hospitalization, the survival time > 90 days;
- The inpatient clinical data are complete.
Exclusion Criteria3
- Human immunodeficiency virus infection or congenital immune deficiency diseases;
- Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival;
- Other conditions that the researchers judged not appropriate for inclusion.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04310787
Related Trials
Evaluation of Patients With Liver Disease
NCT000019711 location
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
NCT060790211 location
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT065628031 location
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
NCT038264331 location
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
NCT0539042411 locations